首站-论文投稿智能助手
典型文献
Resuscitation fluids as drugs: targeting the endothelial glycocalyx
文献摘要:
Fluid resuscitation is an essential intervention in critically ill patients, and its ultimate goal is to restore tissue perfusion. Critical illnesses are often accompanied by glycocalyx degradation caused by inflammatory reactions, hypoperfusion, shock, and so forth, leading to disturbed microcirculatory perfusion and organ dysfunction. Therefore, maintaining or even restoring the glycocalyx integrity may be of high priority in the therapeutic strategy. Like drugs, however, different resuscitation fluids may have beneficial or harmful effects on the integrity of the glycocalyx. The purpose of this article is to review the effects of different resuscitation fluids on the glycocalyx. Many animal studies have shown that normal saline might be associated with glycocalyx degradation, but clinical studies have not confirmed this finding. Hydroxyethyl starch (HES), rather than other synthetic colloids, may restore the glycocalyx. However, the use of HES also leads to serious adverse events such as acute kidney injury and bleeding tendencies. Some studies have suggested that albumin may restore the glycocalyx, whereas others have suggested that balanced crystalloids might aggravate glycocalyx degradation. Notably, most studies did not correct the effects of the infusion rate or fluid volume; therefore, the results of using balanced crystalloids remain unclear. Moreover, mainly animal studies have suggested that plasma may protect and restore glycocalyx integrity, and this still requires confirmation by high-quality clinical studies.
文献关键词:
Fluid resuscitation;Resuscitation fluid;Fluid therapy;Endothelial glycocalyx;Glycocalyx
作者姓名:
Wang Guangjian;Zhang Hongmin;Liu Dawei;Wang Xiaoting;Chinese Critical Ultrasound Study Group
作者机构:
Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100730, China
引用格式:
[1]Wang Guangjian;Zhang Hongmin;Liu Dawei;Wang Xiaoting;Chinese Critical Ultrasound Study Group-.Resuscitation fluids as drugs: targeting the endothelial glycocalyx)[J].中华医学杂志(英文版),2022(02):137-144
A类:
Hydroxyethyl,crystalloids,Glycocalyx
B类:
Resuscitation,fluids,drugs,targeting,endothelial,glycocalyx,Fluid,resuscitation,essential,intervention,critically,patients,its,ultimate,goal,restore,tissue,Critical,illnesses,are,often,accompanied,by,degradation,caused,inflammatory,reactions,hypoperfusion,shock,forth,leading,disturbed,microcirculatory,organ,dysfunction,Therefore,maintaining,restoring,integrity,may,high,priority,therapeutic,strategy,Like,however,different,have,beneficial,harmful,effects,purpose,this,article,review,Many,animal,studies,shown,that,normal,saline,might,associated,but,clinical,not,confirmed,finding,starch,HES,rather,than,synthetic,colloids,However,also,leads,serious,adverse,events,such,acute,kidney,injury,bleeding,tendencies,Some,suggested,albumin,whereas,others,balanced,aggravate,Notably,most,did,correct,infusion,volume,therefore,results,using,remain,unclear,Moreover,mainly,plasma,protect,still,requires,confirmation,quality,therapy,Endothelial
AB值:
0.520372
相似文献
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。